Montelukast thin film - Qilu Pharmaceutical
Alternative Names: Montelukast sodium oral thin film - Qilu PharmaceutucalLatest Information Update: 25 Oct 2022
At a glance
- Originator Qilu Pharmaceutical
- Class Acetates; Anti-inflammatories; Antiasthmatics; Antidementias; Bronchodilators; Neuroprotectants; Nootropics; Quinolines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Unspecified
Most Recent Events
- 14 May 2019 Qilu Pharmaceutical completes pharmacokinetic and bioequivalence clinical trial in Unspecified (In volunteers) in China (PO) (NCT05528198)
- 14 May 2019 Qilu Pharmaceutical completes pharmacokinetic and bioequivalence clinical trial in Unspecified (In volunteers) in China (PO) (NCT05531994)
- 28 Dec 2018 Pharmacokinetic and bioequivalence clinical trial in Unspecified (In volunteers) in China (PO) (NCT05528198)